Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center. Posted on January 9th, 2024 by LEADconnection GoTo Clinical Trial Post navigation Previous: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).Next: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.
Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT). Posted on January 9th, 2024 by LEADconnection GoTo Clinical Trial Post navigation Previous: Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review.Next: Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center.
Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review. Posted on January 9th, 2024 by LEADconnection GoTo Clinical Trial Post navigation Previous: A sitdown with Dr. Bruce Wilkoff, founder of LeadConnection.org, champion of lead management.Next: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).
